Finance

Lists
Why is MRVI down 5,35%?
Dive Deeper
MRVI:NASDAQ
Maravai Lifesciences Holdings Inc
7,43 USD
-5,35%
(-0,42) 1D
7,44 USD
+0,13% (+0,010)
After hours
Closed: 7-окт., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVI...
Open
7,65 USD
High
7,73 USD
Low
7,22 USD
Mkt. cap
1,93 млд
Avg. vol.
3,02 млн
Volume
0,00
52-wk high
9,42 USD
52-wk low
2,57 USD
EPS
-0,53 USD
Beta
0,54
Shares outstanding
148,99 млн
No. of employees
415
Open
7,65 USD
High
7,73 USD
Low
7,22 USD
Mkt. cap
1,93 млд
Avg. vol.
3,02 млн
Volume
0,00
52-wk high
9,42 USD
52-wk low
2,57 USD
EPS
-0,53 USD
Beta
0,54
Shares outstanding
148,99 млн
No. of employees
415
News stories
From web sources and news partners
About Maravai Lifesciences Holdings Inc
CEO-
Employees415
Founded2014
Headquarters-
SectorHealth care
Websitemaravai.com
Analyst ratings
Based on 6 analysts giving stock ratings to MRVI in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MRVI in the last 3 months.
Highest
Current 7,43 USD
9,00 USD (+21,13%)
Average
7,88 USD (+6,06%)
Lowest
6,50 USD (-12,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brendan Smith
TD Cowen
Buy
Initiated
9,00 USD
+21,1%
10/05/2026
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
09/15/2026
Unknown Analyst
UBS
Hold
Initiated
8,00 USD
+7,7%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
8,00 USD
+7,7%
09/09/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
8,00 USD
+7,7%
08/11/2026
Evan Stampler
Wells Fargo
Buy
Maintained
6,50 USD
-12,5%
08/07/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
6,50 USD
-12,5%
08/07/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
08/07/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
05/11/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
6,00 USD
-19,2%
05/08/2026
Catherine Ramsey Schulte
Robert W. Baird
Hold
Maintained
3,00 USD
-59,6%
02/26/2026
Unknown Analyst
Jefferies
Buy
Reiterated
5,00 USD
-32,7%
02/26/2026
Last report
2026-ж., 6-авг.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,02 USD / -0,05 USD
+55,84%beat
Revenue / Est. (USD)
51,44 млн / 49,52 млн
+3,88%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
41,63 млн
49,87 млн
65,84 млн
51,44 млн
Cost of goods sold
35,98 млн
35,32 млн
32,14 млн
30,79 млн
Cost of revenue
35,98 млн
35,32 млн
32,14 млн
30,79 млн
Research and development expenses
3,84 млн
3,79 млн
3,89 млн
3,70 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35,40 млн
30,38 млн
29,09 млн
32,07 млн
Operating expense
39,24 млн
34,17 млн
32,98 млн
35,77 млн
Total operating expenses
75,22 млн
69,50 млн
65,12 млн
66,56 млн
Operating income
-33,58 млн
-19,63 млн
720,00 миң
-15,12 млн
Other non operating income
-71,00 миң
-43,00 миң
-494,00 миң
-52,00 миң
EBT including unusual items
-45,15 млн
-63,01 млн
-6,53 млн
-21,80 млн
EBT excluding unusual items
-37,70 млн
-23,84 млн
-3,65 млн
-18,82 млн
Income tax expense
-92,00 миң
6,00 миң
-151,00 миң
-171,00 миң
Effective tax rate
0,20%
-0,01%
2,31%
0,78%
Other operating expenses
-
-
-
-
Net income
-25,56 млн
-35,68 млн
-3,73 млн
-12,42 млн
Net profit margin
-61,39%
-71,55%
-5,67%
-24,14%
Earnings per share
-0,08
-0,04
0,01
-0,02
Interest and investment income
2,80 млн
2,38 млн
1,87 млн
1,16 млн
Interest expense
-6,84 млн
-6,56 млн
-5,75 млн
-4,81 млн
Net interest expenses
-4,05 млн
-4,17 млн
-3,88 млн
-3,65 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,40 млн
-7,18 млн
12,09 млн
-3,34 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору